Oberman HA. Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol. 1987;11(12):918–29. https://doi.org/10.1097/00000478-198712000-00002. PMID: 2825549.
Altundag K. Different subtypes of metaplastic breast cancer might have different sensitivity to neoadjuvant chemotherapy. J BUON. 2019;24(5):2205 PMID: 31786895.
Lee H, Jung SY, Ro JY, Kwon Y, Sohn JH, Park IH, Lee KS, Lee S, Kim SW, Kang HS, Ko KL, Ro J. Metaplastic breast cancer: clinicopathological features and its prognosis. J Clin Pathol. 2012;65(5):441–6. https://doi.org/10.1136/jclinpath-2011-200586. Epub 2012 Mar 12 PMID: 22412048.
McKinnon E, Xiao P. Metaplastic carcinoma of the breast. Arch Pathol Lab Med. 2015;139(6):819–22. https://doi.org/10.5858/arpa.2013-0358-RS. PMID: 26030252.
Chen IC, Lin CH, Huang CS, Lien HC, Hsu C, Kuo WH, Lu YS, Cheng AL. Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era. Breast Cancer Res Treat. 2011;130(1):345–51. https://doi.org/10.1007/s10549-011-1686-9. Epub 2011 Jul 27 PMID: 21792625.
Du X, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol. 2001;19(5):1455–61. https://doi.org/10.1200/JCO.2001.19.5.1455. PMID: 11230491.
Townsley CA, Selby R, Siu LL. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol. 2005;23(13):3112–24. https://doi.org/10.1200/JCO.2005.00.141. PMID: 15860871.
Extermann M, Aapro M. Assessment of the older cancer patient. Hematol Oncol Clin North Am. 2000;14(1):63–77, viii−ix. https://doi.org/10.1016/s0889-8588(05)70278-1. PMID: 10680072.
Lodi M, Scheer L, Reix N, Heitz D, Carin AJ, Thiébaut N, Neuberger K, Tomasetto C, Mathelin C. Breast cancer in elderly women and altered clinico-pathological characteristics: a systematic review. Breast Cancer Res Treat. 2017;166(3):657–68. https://doi.org/10.1007/s10549-017-4448-5. Epub 2017 Aug 12 PMID: 28803352.
Martinez-Ramos D, Simon-Monterde L, Queralt-Martin R, Suelves-Piqueres C, Menor-Duran P, Escrig-Sos J. Breast cancer in octogenarian. Are we doing our best? A population-registry based study. Breast. 2018;38:81–5. https://doi.org/10.1016/j.breast.2017.12.007. Epub 2018 Jan 4 PMID: 29274475.
Hurria A, Muss H. Special issues in older women with breast cancer. Adv Exp Med Biol. 2015;862:23–37. https://doi.org/10.1007/978-3-319-16366-6_3. PMID: 26059927.
Wang J, Tang J, Chen T, Yue S, Fu W, Xie Z, Liu X. A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study. J Transl Med. 2022;20(1):90. https://doi.org/10.1186/s12967-022-03287-w. PMID:35164796;PMCID:PMC8845298.
Shi H, Yu L, Mai J, Zhang P, Fang K. Nomograms predicting overall survival and cancer-specific survival in metaplastic breast cancer patients. J BUON. 2021;26(4):1386–97 PMID: 34564996.
Li Y, Chen D, Xuan H, Dragomir MP, Calin GA, Meng X, Chen M, Jin H. Construction and validation of prognostic nomogram for metaplastic breast cancer. Bosn J Basic Med Sci. 2022;22(1):131–9. https://doi.org/10.17305/bjbms.2021.5911. PMID:34247567;PMCID:PMC8860321.
Wang J, Zhanghuang C, Tan X, Mi T, Liu J, Jin L, Li M, Zhang Z, He D. Development and validation of a competitive risk model in elderly patients with chromophobe cell renal carcinoma: a population-based study. Front Public Health. 2022;22(10):840525. https://doi.org/10.3389/fpubh.2022.840525. PMID: 35273943; PMCID: PMC8902051.
Glynn RJ, Rosner B, Christen WG. Evaluation of risk factors for cataract types in a competing risks framework. Ophthalmic Epidemiol. 2009;16(2):98–106. https://doi.org/10.1080/09286580902737532. PMID: 19353398; PMCID: PMC3065391.
Jiao S, Guo L, Da F, Gao Q, Ren Z, Wang J, Fu Q, Liu J. Competitive risk model nomogram to predict prognosis in patients aged over 65 years with nonmetastatic cervical cancer: a SEER population-based study. Technol Cancer Res Treat. 2023;22:15330338231164192. https://doi.org/10.1177/15330338231164191. PMID: 37078156; PMCID: PMC10126705.
Li Y, Su P, Wang Y, Zhang H, Liang Y, Zhang N, Song X, Li X, Li J, Yang Q. Impact of histotypes on preferential organ-specific metastasis in triple-negative breast cancer. Cancer Med. 2020;9(3):872–81. https://doi.org/10.1002/cam4.2759. Epub 2019 Dec 9. Erratum in: Cancer Med. 2020 Oct;9(20):7792. PMID: 31814295; PMCID: PMC6997059.
González-Martínez S, Pérez-Mies B, Carretero-Barrio I, Palacios-Berraquero ML, Perez-García J, Cortés J, Palacios J. Molecular features of metaplastic breast carcinoma: an infrequent subtype of triple negative breast carcinoma. Cancers (Basel). 2020;12(7):1832. https://doi.org/10.3390/cancers12071832. PMID:32650408;PMCID:PMC7408634.
Reddy TP, Rosato RR, Li X, Moulder S, Piwnica-Worms H, Chang JC. A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations. Breast Cancer Res. 2020;22(1):121. https://doi.org/10.1186/s13058-020-01353-z. PMID:33148288;PMCID:PMC7640663.
Jung SY, Kim HY, Nam BH, Min SY, Lee SJ, Park C, Kwon Y, Kim EA, Ko KL, Shin KH, Lee KS, Park IH, Lee S, Kim SW, Kang HS, Ro J. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res Treat. 2010;120(3):627–37. https://doi.org/10.1007/s10549-010-0780-8. Epub 2010 Feb 9 PMID: 20143153.
Eaker S, Dickman PW, Bergkvist L, Holmberg L, Uppsala/Orebro Breast Cancer Group. Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med. 2006;3(3):e25. https://doi.org/10.1371/journal.pmed.0030025. PMID: 16409108; PMCID: PMC1326256.
Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;28(12):2038–45. https://doi.org/10.1200/JCO.2009.25.9796. Epub 2010 Mar 22. PMID: 20308658; PMCID: PMC2860406.
Bastiaannet E, Portielje JE, van de Velde CJ, de Craen AJ, van der Velde S, Kuppen PJ, van der Geest LG, Janssen-Heijnen ML, Dekkers OM, Westendorp RG, Liefers GJ. Lack of survival gain for elderly women with breast cancer. Oncologist. 2011;16(4):415–23. https://doi.org/10.1634/theoncologist.2010-0234. Epub 2011 Mar 15. PMID: 21406470; PMCID: PMC3228128.
de Glas NA, Kiderlen M, Vandenbroucke JP, de Craen AJ, Portielje JE, van de Velde CJ, Liefers GJ, Bastiaannet E, Le Cessie S. Performing survival analyses in the presence of competing risks: a clinical example in older breast cancer patients. J Natl Cancer Inst. 2015;108(5):djv366. https://doi.org/10.1093/jnci/djv366. PMID: 26614095.
Park HS, Park S, Kim JH, Lee JH, Choi SY, Park BW, Lee KS. Clinicopathologic features and outcomes of metaplastic breast carcinoma: comparison with invasive ductal carcinoma of the breast. Yonsei Med J. 2010;51(6):864–9. https://doi.org/10.3349/ymj.2010.51.6.864. PMID:20879052;PMCID:PMC2995974.
Cimino-Mathews A, Verma S, Figueroa-Magalhaes MC, Jeter SC, Zhang Z, Argani P, Stearns V, Connolly RM. A clinicopathologic analysis of 45 patients with metaplastic breast carcinoma. Am J Clin Pathol. 2016;145(3):365–72. https://doi.org/10.1093/ajcp/aqv097. Epub 2016 Feb 19 PMID: 27124919.
Tseng WH, Martinez SR. Metaplastic breast cancer: to radiate or not to radiate? Ann Surg Oncol. 2011;18(1):94–103. https://doi.org/10.1245/s10434-010-1198-6. Epub 2010 Jun 29. PMID: 20585866; PMCID: PMC3018259.
Rakha EA, Quinn CM, Foschini MP, Muñoz Martin M, Dabbs DJ, Lakhani S, Varga Z, Pinder SE, Schmitt FC, Reis-Filho JS, Fox SB, Ellis IO, Tan PH, Mihai R. Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management. Histopathology. 2021;78(5):759–71. https://doi.org/10.1111/his.14290. Epub 2020 Dec 16. PMID: 33113154; PMCID: PMC8492009.
Speers C, Pierce LJ. Postoperative radiotherapy after breast-conserving surgery for early-stage breast cancer: a review. JAMA Oncol. 2016;2(8):1075–82. https://doi.org/10.1001/jamaoncol.2015.5805. PMID: 27243924.
Hu J, Dong F, Zhang Y, Shen J, Ming J, Huang T. Triple-negative metaplastic breast cancer: treatment and prognosis by type of surgery. Am J Transl Res. 2021;13(10):11689–96. PMID: 34786095; PMCID: PMC8581904.
